One European stock market has clawed back most of its losses in 2020, thanks to a heavy weighting of health-care stocks. And it’s not Switzerland.
Denmark’s OMX Copenhagen 25 Index on Thursday came within 2% of turning positive for the year. The reason? Roughly half the benchmark’s weighting comes from pharma shares, which have proven more resilient than most in a global economy ravaged by the impact of the coronavirus. Green stocks have also boosted the gauge.